FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
Do you really want to know you have Alzheimer’s?
By
John O'Connor
May 05, 2022
Would you want to know if Alzheimer’s disease is starting to feast on your brain? It turns out the answer soon might be in your hands.
Inverse link found for antioxidant levels, all-cause dementia
May 04, 2022
Serum lutein+zeaxanthin and β-cryptoxanthin levels were inversely associated with incident all-cause dementia.
Smartphones: ‘digital dementia’ contributor or cognitive memory aid?
By
Kimberly Bonvissuto
May 04, 2022
Smartphones: friend or foe? It depends on whom you ask. Recent studies on smartphone use have found that mobile technology either can contribute to cognitive impairment or help improve cognition.
Assisted living operators can change ‘long-term care’ narrative through partnerships
By
Kimberly Bonvissuto
Apr 12, 2022
When it comes to “long-term care,” assisted living tends to be ignored. But providers can change that narrative by networking and being full partners in opportunities, especially when it comes to clinical...
Dementia training tied to license renewals for emergency services workers
By
Kimberly Bonvissuto
Apr 07, 2022
Emergency medical services workers will be required to undergo training on caring and treating individuals with Alzheimer’s disease and other dementias under a new bill passed by the Illinois Legislature.
Improved dementia diagnosing can lead to better advanced care planning: study
By
Kimberly Bonvissuto
Apr 04, 2022
Medical providers are diagnosing Alzheimer’s disease and related dementias in older adults more frequently than in the past, providing opportunities for better advanced care planning, according to the...
Dementia to cost nation $321 billion this year, Alzheimer’s Association says
By
Kimberly Bonvissuto
Mar 16, 2022
This year, Alzheimer’s and other dementias will cost the nation $321 billion, increasing to $1 trillion by 2050, according to a report released Tuesday by the Alzheimer’s Association.
Spa program reduces use of antipsychotics, other meds in memory care residents
By
Kimberly Bonvissuto
Mar 14, 2022
When Sunshine Retirement Living officials saw a significant drop in the use of antipsychotics in its memory care residents after piloting a “sensory spa” in one community, its mission became clear....
Senate committee backs Califf nomination to head FDA
Jan 14, 2022
Among those who voted against Califf’s nomination were Democrats who expressed concerns about his links to pharmaceutical companies.